2021-07-16T12:37:45-05:00 2020-12-31 BKD LLP 1155 Avenue of the Americas 1200 New York NY 10036 990 2020-01-01 132890727 Guttmacher Institute Inc % MAUREEN BURNLEY GUTT 2122481111 125 Maiden Lane 7th Floor New York NY 10038 MAUREEN BURNLEY VP FINANCE AND ADMIN 2122481111 2020-06-15 true MAUREEN BURNLEY 999009999 Aaron Shapiro P01333816 2128674000 2 2020 2022-09-23 18:48:47Z MAUREEN BURNLEY 125 MAIDEN LANE 7TH FLOOR NEW YORK NY 10038 41740778 false X WWW.GUTTMACHER.ORG X 1977 NY THE INSTITUTE IS A LEADING RESEARCH AND POLICY ORGANIZATION COMMITTED TO ADVANCING SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS IN THE UNITED STATES AND GLOBALLY. 24 24 168 30 0 17411971 18034032 45235 46420 1481023 1214542 229365 45567 19167594 19340561 0 0 0 0 18372023 19715266 0 0 1689630 10025931 7958578 28397954 27673844 -9230360 -8333283 67814354 71778820 10417131 21131932 57397223 50646888 X THE GUTTMACHER INSTITUTE IS A LEADING RESEARCH AND POLICY ORGANIZATION COMMITTED TO ADVANCING SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS IN THE UNITED STATES AND GLOBALLY. THE INSTITUTE ENVISIONS A WORLD IN WHICH ALL PEOPLE ARE ABLE TO EXERCISE THEIR RIGHTS AND RESPONSIBILITIES REGARDING SEXUAL BEHAVIOR AND REPRODUCTION FREELY AND WITH DIGNITY. THE INSTITUTE PRODUCES A WIDE RANGE OF RESOURCES ON TOPICS PERTAINING TO SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS, INCLUDING TWO PEER-REVIEWED JOURNALS (PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH AND INTERNATIONAL PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH), THE GUTTMACHER POLICY REVIEW, AND A MULTITUDE OF REPORTS, ISSUE BRIEFS, FACT SHEETS AND INFOGRAPHICS. ITS WEBSITE RECEIVES 7.7 MILLION PAGE VIEWS ANNUALLY. GUTTMACHER IS THE RECIPIENT OF THE 2018 UN POPULATION AWARD. false false 13045591 Research: In 2020, our Research team generated a wide range of timely evidence, including influential research on the impact of COVID-19 on sexual and reproductive health. At a time when many assumed that the pandemic would lead to a spike in birth rates, our research foreshadowed the "baby bust" that has since been reported extensively in the media and borne out by national data on births. This study also highlighted the disproportionate impact of the pandemic on low-income women, women of color, and Queer women and made a compelling case to increase access to safety-net family planning services to address these inequities. At the state level, we analyzed the potential impact of abortion restrictions that policymakers sought to impose during the pandemic and deepened collaborations with stakeholders to ensure that we could deliver policy-relevant findings to help inform state policy debates. Our pandemic-responsive research also included an extensively-cited set of projections of the impact of COVID-19 on reproductive health in low- and middle-income countries. Through a collaboration with the World Health Organization, we published the latest round of our global, regional and sub-regional estimates of unintended pregnancy and abortion, through a widely cited article in the Lancet Global Health. We also released the latest iteration of our flagship Adding It Up report on the costs and benefits of investing in sexual and reproductive health globally, along with the accompanying "Just the Numbers" analysis documenting the impact of U.S. international family planning assistance (which was widely cited by policymakers and advocates). Guttmacher researchers published the findings of studies in a range of top-rated peer-reviewed journals and in scientific reports and other publications. Building on decades of collaborative work, we also expanded our program of research capacity-strengthening for organizations in a number of countries. 6439021 46420 Communications and Publications: The Institute shaped and informed media coverage and public debate on sexual and reproductive health and rights throughout 2020. We strategically disseminated the Institute's evidence and analyses in a range of formats and across a multitude of platforms, targeting key stakeholders and influencers including advocates, health care providers, policymakers and their staff, media and the scientific community. Among the results of these outreach efforts was extensive media coverage in high-profile news outlets, including the New York Times, Washington Post, The Guardian, NPR, Reuters, Politico, NBC News, and CNN. The Institute's experts also authored a number of high-impact op-eds and blog posts. For example, Dr. Palacio co-authored an op-ed in the Washington Post that laid out a series of evidence-based recommendations for the incoming Biden Administration; and two of our experts authored an op-ed in the Colorado Sun that documented our analysis of the harmful impact of a ballot amendment that would have restricted access to abortion in Colorado (the amendment was ultimately voted down). We intensified our longstanding efforts to equip US advocates with the evidence-based resources needed to fight back against restrictive policies and to advance proactive policies, and we worked closely with partner organizations in low- and middle-income countries to strengthen their capacity to effectively communicate for evidence-based policy change within their own countries and regions. 2430313 Public Policy: The Institute worked to advance evidence-based policies at the state, national and global levels. We did this by monitoring and reporting on trends in state policies, providing Congressional testimony, engaging in educational briefings for policymakers and their staff, providing the factual foundation for litigation, and leading and participating in a range of federal coalitions. Highlights included helping lay the evidentiary foundation for the Supreme Court's 5-4 decision to strike down Louisiana's law restricting the provision of abortion services in June Medical Services v. Russo. In a pair of amicus briefs, Guttmacher scientists and other researchers outlined how Louisiana's law would undermine women's equality and threaten their economic security, health, safety, and autonomy. Of the 27 briefs submitted to the Supreme Court, 16 cited Guttmacher resources. Later in the year, Guttmacher CEO Dr. Herminia Palacio provided expert testimony before the U.S. House Appropriations Labor, Health and Human Services Subcommittee on the harms of the Hyde Amendment. Finally, Guttmacher policy staff played a key role in preparing for the incoming administration and Congress to lay the groundwork for important policy actions early in 2021, such as the rescinding of the Global Gag Rule and inclusion in the American Rescue Plan Act of $50 million in supplemental funds for the Title X family planning program. 21914925 true true false true false false false false false true true false false true true false true false false true true false false false false false false false false true false false false false false false false false true false false false false false false false false true 54 0 168 true false false false false false false false false false false false false X 24 24 false false false false false false false true true false false true true true true true true true true false AL AR CA FL GA HI IL KS KY MD MA MI MN MS NH NJ NM NY NC OR PA RI SC TN UT VA WV WI X MAUREEN BURNLEY 2122481111 125 MAIDEN LANE 7TH FLOOR NEW YORK NY 10038 HERMENIA PALACIO PRESIDENT & CEO 35.0 0.0 X 349988 0 55739 SUSHEELA SINGH DISTINGUISHED SCHOLAR & VP FOR 35.0 0.0 X 321150 0 77267 JONATHAN WITTENBERG EXECUTIVE VICE PRESIDENT 35.0 0.0 X 265995 0 71426 KATHRYN KOST DIRECTOR OF DOMESTIC RESEARCH 35.0 0.0 X 246841 0 77011 MAUREEN BURNLEY VP FINANCE & ADMINISTRATION 35.0 0.0 X 245299 0 55464 HEATHER BOONSTRA VP FOR PUBLIC POLICY 35.0 0.0 X 238161 0 56136 MAIBE PONET VP FOR COMMUNICATIONS & PUBLIC 35.0 0.0 X 241288 0 51730 KATHLEEN RANDALL DIRECTOR OF PRODUCTION 35.0 0.0 X 212101 0 58085 LAURA LINDBERG PRINCIPAL RESEARCH SCIENTIST 35.0 0.0 X 190451 0 72486 JENNIFER FROST PRINCIPAL RESEARCH SCIENTIST 35.0 0.0 X 208368 0 32770 ANN BIDDLECOM Dir of International Research 35.0 0.0 X 219493 0 21136 ALETHA AKERS VP FOR RESEARCH 35.0 0.0 X 213698 0 6392 SILVIA HENRIQUEZ Board CHAIR 1.0 0.0 X X 0 0 0 Lou Turner Zellner Chair/Immediate Past Chair 1.0 0.0 X X 0 0 0 MARY SHALLENBERGER thru 620 IMMEDIATE PAST CHAIR 0.25 0.0 X X 0 0 0 ERNESTINA COAST VICE CHAIR 1.0 0.0 X X 0 0 0 Laura Philips Chair, Finance Committee/TREAS 1.0 0.0 X X 0 0 0 MICHAEL KLEIN CHAIR, AUDIT COMMITTEE/SECRETA 0.5 0.0 X X 0 0 0 Pamela Merritt Member at Large/ Secretary 0.5 0.0 X X 0 0 0 CONSTANCE MAO CHAIR, DEVELOPMENT COMMITTEE 0.5 0.0 X 0 0 0 MARCELA HOWELL MEMBER AT LARGE thru 6/20 0.1 0.0 X 0 0 0 SUJATHA JESUDASON MEMBER AT LARGE 0.5 0.0 X 0 0 0 PAUL SPERRY MEMBER AT LARGE thru 6/20 0.5 0.0 X 0 0 0 AMANDA COOPER thru 620 CHAIR, NOMINATING & GOVERNANCE 0.5 0.0 X 0 0 0 CYNTHIA GOMEZ CHAIR, NOMINATING & GOVERNANCE 0.5 0.0 X 0 0 0 Laura Rosenbury Chair, Development Committee 0.5 0.0 X 0 0 0 JUDY TABB thru 620 CHAIR, AUDIT COMMITTEE 0.5 0.0 X 0 0 0 ALAN GUTTMACHER DIRECTOR 0.5 0.0 X 0 0 0 SUSAN FRELICH APPLETON DIRECTOR 0.5 0.0 X 0 0 0 ERIN ARMSTRONG DIRECTOR 0.5 0.0 X 0 0 0 JOTHAM MUSINGUZI DIRECTOR 0.5 0.0 X 0 0 0 DANIEL PELLEGROM DIRECTOR 0.5 0.0 X 0 0 0 Lida Coleman DIRECTOR 0.5 0.0 X 0 0 0 Ketayoun Darvich- Kodjouri DIRECTOR 0.5 0.0 X 0 0 0 NOZER SHERIAR DIRECTOR 0.5 0.0 X 0 0 0 BARBARA SINGHAUS DIRECTOR 0.5 0.0 X 0 0 0 JANE LEUNG DIRECTOR 0.5 0.0 X 0 0 0 DENISE SPILLANE DIRECTOR 0.5 0.0 X 0 0 0 ERICA DUIGNAN MINNIHAN DIRECTOR 0.5 0.0 X 0 0 0 LISA IKEMOTO DIRECTOR thru 6/20 0.25 0.0 X 0 0 0 PAUL VAN LOOK DIRECTOR thru 6/20 0.5 0.0 X 0 0 0 KIERRA JOHNSON DIRECTOR 0.5 0.0 X 0 0 0 2952833 0 635642 56 false true false NORC AT THE UNIVERSITY OF CHICAGO 55 EAST MONROE STREET CHICAGO IL 60603 PRGRM SUBCONTRACTOR 934406 JOHN HOPKINS UNIVERSITY 3400 N CHARLES STREET BALTIMORE MD 21218 PRGRM SUBCONTRACTOR 256856 SEWARD KISSEL LLP 1 BATTERY PARK PLAZA NEW YORK NY 10004 LEGAL SERVICES 170110 PRODUCTION SOLUTIONS INC 1953 GALLOWS RD SUITE 500 VIENNA VA 22182 ACQUISITION MAILING 161135 ATEN 3507 RINGSBY CT NO 111 DENVER CO 80216 WEBSITE TECH CONSULT 227141 8 724517 17309515 6196764 18034032 PUBLICATIONS 900099 46420 46420 46420 495361 495361 0 31510 31510 0 0 0 23119398 22400217 719181 719181 719181 0 0 0 0 0 0 0 0 0 OTHER 900099 14057 14057 14057 19340561 46420 1260109 0 0 0 0 2249733 1365588 618676 265469 0 13524420 11521264 1379671 623485 1105284 945288 108598 51398 1813606 1545568 182262 85776 1022223 843652 122223 56348 0 190502 98732 91770 73970 73970 19876 19876 0 114078 114078 3267247 2915447 351800 0 473518 287949 141282 44287 410395 171640 214735 24020 0 2107903 1316414 684493 106996 106500 74654 30402 1444 0 81882 57397 23375 1110 0 0 775987 584975 143259 47753 190109 118725 61734 9650 PRINTING AND ARTWORK 45418 27128 18290 MISCELLANEOUS 101193 20628 78761 1804 27673844 21914925 4069289 1689630 135836 79686 16499228 19551204 15751845 5889703 115944 656082 0 0 0 0 0 0 0 0 196439 254170 19750182 10266098 9849655 9484084 24741609 28566819 312599 336312 0 0 0 0 211199 6960760 67814354 71778820 1327353 1522987 0 0 0 0 8128653 0 0 0 0 0 0 8339078 0 3043300 961125 8226567 10417131 21131932 X 16960738 18704979 40436485 31941909 57397223 50646888 67814354 71778820 X -8333283 1751059 -168111 X false true X true false X 23453108 16837307 9909078 17411971 18034032 85645496 0 0 23453108 16837307 9909078 17411971 18034032 85645496 29105880 56539616 394380 371690 751326 771265 526871 2815532 0 10943 47811 25996 207690 14057 306497 88767525 177660 0.63694 0.60484 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 19876 19876 27194136 27214012 1000000 250000 1000000 1000000 1000000 1000000 4000000 6000000 15463 10709 8901 19876 54949 250000 250000 250000 250000 1000000 1500000 7888871 1207790 263232 8833429 6487915 1650464 249508 7888871 7151837 -428239 235683 6487915 6200727 1169827 218717 7151837 6170054 237739 207066 6200727 0.53030 0.46970 false false 11966673 3933518 8033155 2398694 1611569 787125 3136216 2711271 424945 1759168 1520309 238859 9484084 SECURITY DEPOSITS 211199 RIGHT OF USE ASSET-OPER. LEASE 6749561 6960760 0 OPERATING LEASE LIABILITIES 7337943 POSTRETIREMENT BENEFITS 888624 8226567 20809431 1751059 -168111 1582948 19226483 114078 114078 19340561 27559766 27559766 114078 114078 27673844 SCHEDULE D, PART V, LINE 4 THE INSTITUTE'S ENDOWMENTS CONSIST OF A DONOR-RESTRICTED ENDOWMENT FUND TO BE USED FOR GENERAL OPERATIONS AND ENDOWMENT GIFTS TOTALING $1 MILLION TO BE USED FOR BIXBY FELLOWSHIPS. Part XI, line 2d OTHER ADJUSTMENTS: POSTRETIREMENT BENEFITS ADJUSTMENT -87,025 Foreign Exchange Gain -81,086 Central America and the Caribbean 0 2 Program Services RESEARCH AND COMMS 17707 Europe (Including Iceland and Greenland) 0 5 Program Services RESEARCH AND COMMS 88003 South America 0 2 Program Services RESEARCH AND COMMS 46005 South Asia 0 7 Program Services RESEARCH AND COMMS 106734 Sub-Saharan Africa 0 19 Program Services RESEARCH AND COMMS 211029 0 35 0 35 469478 469478 false false false false false false X X X false false false false false false false false false HERMENIA PALACIO PRESIDENT & CEO 348956 0 0 0 1032 0 23187 0 32552 0 405727 0 JONATHAN WITTENBERG EXECUTIVE VICE PRESIDENT 265755 0 0 0 240 0 27500 0 43926 0 337421 0 MAUREEN BURNLEY VP FINANCE & ADMINISTRATION 243715 0 0 0 1584 0 25138 0 30326 0 300763 0 KATHRYN KOST DIRECTOR OF DOMESTIC RESEARCH 245257 0 0 0 1584 0 25390 0 51621 0 323852 0 ANN BIDDLECOM Dir of International Research 219300 0 0 0 193 0 21076 0 60 0 240629 0 KATHLEEN RANDALL DIRECTOR OF PRODUCTION 210517 0 0 0 1584 0 21721 0 36364 0 270186 0 JENNIFER FROST PRINCIPAL RESEARCH SCIENTIST 206784 0 0 0 1584 0 20625 0 12145 0 241138 0 LAURA LINDBERG PRINCIPAL RESEARCH SCIENTIST 189595 0 0 0 856 0 19315 0 53171 0 262937 0 SUSHEELA SINGH DISTINGUISHED SCHOLAR & VP FOR 316206 0 0 0 4944 0 32583 0 44684 0 398417 0 ALETHA AKERS VP FOR RESEARCH 213473 0 0 0 225 0 6392 0 0 0 220090 0 MAIBE PONET VP FOR COMMUNICATIONS & PUBLIC 240928 0 0 0 360 0 12250 0 39480 0 293018 0 HEATHER BOONSTRA VP FOR PUBLIC POLICY 237288 0 0 0 873 0 24500 0 31636 0 294297 0 X 12 6196764 COMPARABLE SALES false true false part i, column (b) this represents the number of contributions. FORM 990, PART VI, SECTION B, LINE 11B THE AUDIT COMMITTEE IS RESPONSIBLE FOR REVIEWING AND APPROVING THE 990 BEFORE SUBMISSION. IF THERE ARE ANY QUESTIONS, THEY ARE DISCUSSED WITH THE TAX PREPARER AND RESOLVED TO THE COMMITTEE'S SATISFACTION. ONCE THE AUDIT COMMITTEE HAS SIGNED OFF, THE 990 IS EMAILED TO ALL BOARD MEMBERS AND THEY ARE ASKED TO CONFIRM THAT THEY HAVE RECEIVED THE FORM 990. FORM 990, PART VI, SECTION B, LINE 12C OFFICERS, KEY EMPLOYEES AND DIRECTORS ARE REQUIRED TO REVIEW, DISCLOSE POTENTIAL CONFLICTS, AND SIGN THE CONFLICT OF INTEREST POLICY ANNUALLY. THE AUDIT COMMITTEE GATHERS ALL MATERIAL FACTS CONCERNING ANY DISCLOSED CONFLICTS. THE INFORMATION IS PROVIDED TO THE BOARD OF DIRECTORS FOR DELIBERATION. IF NECESSARY, THE BOARD VOTES UPON THE APPROPRIATE ACTION WHILE THE INTERESTED PERSON IS EXCUSED. FORM 990, PART VI, SECTION B, LINE 15A & 15B AN EXECUTIVE COMPENSATION COMMITTEE, CONSISTING OF THE BOARD CHAIR, THE FINANCE COMMITTEE CHAIR, AND THE IMMEDIATE PAST BOARD CHAIR, SETS COMPENSATION FOR THE CEO AND REVIEWS COMPENSATION FOR ALL OTHER OFFICERS (I.E. VICE PRESIDENTS). THESE INDIVIDUALS EXERCISE SUBSTANTIAL INFLUENCE OVER THE AFFAIRS OF THE INSTITUTE AND ARE, AS SUCH, DISQUALIFIED PERSONS WITHIN THE MEANING OF SECTION 4958(F)(1) OF THE INTERNAL REVENUE CODE. THE EXECUTIVE COMPENSATION COMMITTEE'S PRIMARY PURPOSE IS TO ENSURE THAT EXECUTIVE COMPENSATION PACKAGES REPRESENT REASONABLE REMUNERATION FOR THE SERVICES PREFORMED AND TO ENSURE COMPLIANCE WITH ALL APPLICABLE FEDERAL, STATE AND LOCAL LAWS. PRIOR TO THE OCTOBER BOARD MEETING, THE COMMITTEE REVIEWS COMPENSATION FOR SENIOR EXECUTIVES AT COMPARABLE NON-PROFIT ORGANIZATIONS, WITH STAFFING LEVELS AND BUDGETS ON PAR WITH THOSE OF THE INSTITUTE, AND WHICH CONDUCT ACTIVITIES SIMILAR IN SCOPE AND PURPOSE TO THOSE OF THE INSTITUTE, IN ORDER TO BENCHMARK OUR COMPENSATION PRACTICES FOR OFFICERS. THE COMMITTEE MAY ALSO REVIEW SURVEYS COMPILED BY INDEPENDENT FIRMS AND OTHER ORGANIZATIONS' PUBLIC DOCUMENTATION OF SALARY PRACTICES. THE COMMITTEE REPORTS ITS COMPENSATION DETERMINATIONS ANNUALLY TO THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE AND THE BOARD OF DIRECTORS MUST APPROVE THE CEO COMPENSATION PACKAGE AND BE INFORMED OF THE COMPENSATION OF THE OTHER OFFICERS. THIS PROCESS for the 2020 salaries was CONDUCTED IN OCTOBER 2019. subsequently another review was done in October 2020 for the 2021 salaries. FORM 990, PART VI, SECTION C, LINE 19 MEMBERS OF THE PUBLIC MAY REQUEST A COPY OF THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS BY PHONE, EMAIL OR MAIL. COPIES OF THE REQUESTED DOCUMENTS ARE SENT TO THEM VIA THE MEDIUM OF THEIR CHOICE. FORM 990, PART XI, LINE 9 OTHER CHANGES IN NET ASSETS: CHANGE IN POSTRETIREMENT BENEFITS -87,025 FOREIGN EXCHANGE GAIN -81,086 ---------- TOTAL -168,111 FORM 990 PART IX LINE 11G DESCRIPTION:SUB-CONTRACTS TOTAL FEES:1634370 FORM 990 PART IX LINE 11G DESCRIPTION:CONSULTANTS TOTAL FEES:1415326 FORM 990 PART IX LINE 11G DESCRIPTION:TEMPORARY HELP TOTAL FEES:134351 FORM 990 PART IX LINE 11G DESCRIPTION:RECRUITMENT COSTS TOTAL FEES:83200